Guan, J. (2021) “Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis”, EXCLI Journal, 20, pp. 1–16. doi: 10.17179/excli2020-3111.